生命科学资讯

Tackling antimicrobial resistance, one genome at a time - Illumina

Agilent to Participate in Citi’s 2025 Global Healthcare Conference - Business Wire

Thermo Fisher Scientific Opens East Coast Collaboration Center at BioLabs - citybiz

Agilent Wants Justices To Eye Invalidation Of CRISPR Patents - Law360

Roche Had A Positive Cancer Study — And Its Rival Flew 130% - Investor's Business Daily

10x Genomics at Wolfe Research Healthcare: Navigating Challenges and Opportunities - Investing.com

Thermo Fisher targets early-stage CGT bottlenecks with new Philadelphia hub - R&D World

Roche pill notches win in early breast cancer - BioPharma Dive

Raiffeisen Bank International AG Raises Holdings in Agilent Technologies, Inc. $A - MarketBeat

Lab-grown models of human brains are advancing rapidly. Can ethics keep pace?

CRISPR/Cas9 Knock-In Tagging: Simplifying the Study of Endogenous Biology

Roche's oral SERD notches second pivotal breast cancer win - FirstWord Pharma

OLMA Stock Doubles After Roche Cancer Drug Trial Yields Positive Results - Stocktwits

Roche's oral SERD goes 2 for 2, hitting goal in phase 3 adjuvant breast cancer trial - Fierce Biotech

10x Genomics (Nasdaq: TXG) Xenium Powers ASTRA Atlas of 2,000 Asia-Pacific Tumor Samples - Stock Titan

New ASTRA Consortium Unites Asia-Pacific Scientists to Build Pan-Cancer Spatial Atlas Powered by 10x Genomics' Xenium - PR Newswire

Freenome Announces Exclusive Agreement with Roche to Expand Technology Collaboration and Develop and Commercialize Cancer Screening Tests Outside the U.S. - PR Newswire

Roche touts early giredestrant success | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

Monster Beverage, UnitedHealth, Thermo Fisher Scientific And More: CNBC's 'Final Trades' - Benzinga

Roche boosts Olema as breast cancer therapy succeeds in late-stage trial - Seeking Alpha